Skip to main content
. 2013 Aug 23;122(14):2433–2442. doi: 10.1182/blood-2012-12-472183

Figure 2.

Figure 2

miR-30c is downregulated in normal karyotype AML patient samples with CEBPA mutations. (A) Q-RT-PCR for miR-30c was carried out using bone marrow cells derived from AML patient samples (n = 30) and healthy donors (n = 3). Values were normalized to U6 and further to the expression level of 3 healthy donors. (B) Q-RT-PCR for miR-30c was carried out using bone marrow cells derived from AML patient samples with monoallelic (n = 4), biallelic (n = 4), and without CEBPA mutations (n = 4). Values were normalized to U6 and further to the expression level of CEBPA mutations negative.